Abstract
The binding of Fas ligand to Fas recruits caspase 8 to Fas via an adaptor, FADD/MORT1, and activates a caspase cascade leading to apoptosis. Here, we describe a human Jurkat-derived cell line (JB-6) that is deficient in caspase 8. This cell line was resistant to the apoptosis triggered by Fas engagement. However, the multimerization of Fas-associated protein with death domain, through the use of a dimerizing system, killed the JB-6 cells. This killing process was not accompanied by the activation of caspases or DNA fragmentation. The dying cells showed neither condensation nor fragmentation of cells and nuclei, but the cells and nuclei swelled in a manner similar to that seen in necrosis. These results suggested that Fas-associated protein with death domain can kill the cells via two pathways, one mediated by caspases and another that does not involve them.
MeSH Terms
Adaptor Proteins, Signal Transducing
Apoptosis/physiology
Carrier Proteins/chemistry,genetics,metabolism
Caspase 8
Caspase 9
Caspases/metabolism
Cell Death/physiology
Cell Line, Transformed
Fas Ligand Protein
Fas-Associated Death Domain Protein
Humans
Immunophilins/genetics,metabolism
Jurkat Cells
Membrane Glycoproteins/metabolism
Microscopy, Electron
Necrosis
Protein Conformation
Tacrolimus Binding Proteins
fas Receptor/metabolism
Chemicals
Adaptor Proteins, Signal Transducing
Carrier Proteins
FADD protein, human
FASLG protein, human
Fas Ligand Protein
Fas-Associated Death Domain Protein
Membrane Glycoproteins
fas Receptor
CASP8 protein, human
CASP9 protein, human
Caspase 8
Caspase 9
Caspases
Tacrolimus Binding Proteins
Immunophilins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kawahara A
Department of Genetics, Osaka University Medical School, Yamada-oka, Suita, Osaka 565-0871, Japan.
Ohsawa Y
Matsumura H
Uchiyama Y
Nagata S
References (30)
30 references, click to expand
-
A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain.
J Biol Chem. 1995 Apr 7;270(14):7795-8
PMID: 7536190
-
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.
Cell. 1993 Dec 17;75(6):1169-78
PMID: 7505205
-
Caspases: killer proteases.
Trends Biochem Sci. 1997 Aug;22(8):299-306
PMID: 9270303
-
Caspases: the executioners of apoptosis.
Biochem J. 1997 Aug 15;326 ( Pt 1):1-16
PMID: 9337844
-
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD.
Nature. 1998 Jan 1;391(6662):43-50
PMID: 9422506
-
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis.
Nature. 1998 Jan 1;391(6662):96-9
PMID: 9422513
-
Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor.
J Exp Med. 1998 May 4;187(9):1477-85
PMID: 9565639
-
Fas-induced DNA fragmentation and proteolysis of nuclear proteins.
Genes Cells. 1998 May;3(5):297-306
PMID: 9685181
-
Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally.
Immunity. 1998 Aug;9(2):267-76
PMID: 9729047
-
Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways.
J Exp Med. 1998 Sep 7;188(5):919-30
PMID: 9730893
-
FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.
Cell. 1995 May 19;81(4):505-12
PMID: 7538907
-
Apoptosis by a cytosolic extract from Fas-activated cells.
EMBO J. 1995 Nov 1;14(21):5201-8
PMID: 7489709
-
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.
EMBO J. 1995 Nov 15;14(22):5579-88
PMID: 8521815
-
Transducers of life and death: TNF receptor superfamily and associated proteins.
Oncogene. 1996 Jan 4;12(1):1-9
PMID: 8552378
-
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
Cell. 1996 Jan 26;84(2):299-308
PMID: 8565075
-
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis.
Nature. 1996 Apr 25;380(6576):723-6
PMID: 8614469
-
FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis.
J Biol Chem. 1996 Mar 1;271(9):4961-5
PMID: 8617770
-
Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death.
Cell. 1996 Jun 14;85(6):803-15
PMID: 8681376
-
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.
Cell. 1996 Jun 14;85(6):817-27
PMID: 8681377
-
In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains.
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7464-9
PMID: 8755496
-
Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization.
Curr Biol. 1996 Jul 1;6(7):839-47
PMID: 8805308
-
Apoptosis by death factor.
Cell. 1997 Feb 7;88(3):355-65
PMID: 9039262
-
Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling.
J Biol Chem. 1997 Mar 7;272(10):6578-83
PMID: 9045686
-
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.
Nature. 1980 Apr 10;284(5756):555-6
PMID: 6245367
-
Cell death: the significance of apoptosis.
Int Rev Cytol. 1980;68:251-306
PMID: 7014501
-
pEF-BOS, a powerful mammalian expression vector.
Nucleic Acids Res. 1990 Sep 11;18(17):5322
PMID: 1698283
-
Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity.
Oncogene. 1993 Apr;8(4):1075-81
PMID: 8455935
-
A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen.
J Biol Chem. 1993 May 25;268(15):10932-7
PMID: 7684370
-
Controlling signal transduction with synthetic ligands.
Science. 1993 Nov 12;262(5136):1019-24
PMID: 7694365
-
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.
Br J Cancer. 1972 Aug;26(4):239-57
PMID: 4561027